[Show all top banners]

Himalaya178

More by Himalaya178
What people are reading
Subscribers
Subscribers
[Total Subscribers 2]

tintotopi

Geology Tiger
:: Subscribe
Back to: Kurakani General Refresh page to view new replies
 Layoffs at Glaxo SmithKline
[VIEWED 1306 TIMES]
SAVE! for ease of future access.
Posted on 06-11-08 9:58 AM     Reply [Subscribe]
Login in to Rate this Post:     0       ?    
 

Hundreds of highly paid GlaxoSmithKline scientists will find out today whether they still have jobs as the drug maker steps up a restructuring program it announced in October to counter slow sales.

A GSK spokeswoman acknowledged the job cuts but declined to provide details, except to say that employees will be notified this week and receive severance packages.

"There is a whole lot of reshuffling going on companywide," said Melinda Stubbee. "Unfortunately, as part of that process, jobs are going to be lost."

The layoffs have been in the works for weeks, said Stephen Frye, GSK's former head of drug discovery, who joined the UNC-Chapel Hill faculty last year. Frye said he has been talking to several former colleagues who were worried about losing their jobs.

GSK plans to eliminate half of about 500 jobs at its two research and development centers in Philadelphia and RTP, Frye said his former colleagues told him. The centers are involved in finding treatments for cardiovascular and metabolic diseases, including diabetes. Stubbee would not confirm that information. GSK now employs 4,700 in RTP.

Managers overseeing research projects expected to learn Tuesday whether they would be laid off, Frye said. Staff scientists await word today.

GSK's restructuring has been fueled by rising competition from generic drugs, heightened regulatory scrutiny and about $2.5 billion in lost sales of Avandia -- a best-selling diabetes pill until a study published in May 2007 linked it to an increased risk of heart attack. The drug maker is also facing patent expirations of drugs that are likely to generate $4.6 billion in annual sales this year.

Analyst Steve Scala with Cowen, a New York investment bank, in a research note published Tuesday reduced his forecast for GSK sales for each of the next three years.

Like other large pharmaceutical companies that have shed thousands of jobs in sales and research in the past year, GSK is trying to get leaner and more efficient.

In February, the British drug maker cut an undisclosed number of jobs at its U.S. headquarters in RTP. Three months later, the company laid off 70 employees at its manufacturing plant in Zebulon.

At the same time, GSK is shifting research and development activities to lower-cost countries, including China, and partnering with smaller biotech companies to come up with new drugs.

The shift doesn't mean GSK is cutting research programs, Stubbee said.

"Big pharma players can no longer hope to generate the absolutely best science in all areas on their own," Jean-Pierre Garnier, GSK's former chief executive, wrote in the Harvard Business Review last month. "Therefore, standard operating procedure should be to decide on a scientific bet, shop around among all the external players that are pursuing such research, and establish a contractual relationship with the best."

The restructuring program, which aims to save as much as $1.4 billion annually over three years, was initiated on Garnier's watch. Garnier retired last month and has been replaced by Andrew Witty, who pledged to boost GSK's investment in new drugs discovered outside the company.

To determine whom to lay off, GSK asks all employees in targeted areas to interview for the remaining positions, Frye said. That means the GSK employees who lose their jobs this week have gone through the interview process twice in the past year.

Many are disillusioned with the company they once thought was a good place to be, Frye said. Recently, he said, "people say GSK is a good place to be from

 


 


Please Log in! to be able to reply! If you don't have a login, please register here.

YOU CAN ALSO



IN ORDER TO POST!




Within last 200 days
Recommended Popular Threads Controvertial Threads
TPS Re-registration
What are your first memories of when Nepal Television Began?
निगुरो थाहा छ ??
ChatSansar.com Naya Nepal Chat
Basnet or Basnyat ??
Sajha has turned into MAGATs nest
NRN card pros and cons?
Do nepalese really need TPS?
कता जादै छ नेपाली समाज ??
susta manasthiti lai ke bhanchan english ma?
Nas and The Bokas: Coming to a Night Club near you
Will MAGA really start shooting people?
Democrats are so sure Trump will win
मन भित्र को पत्रै पत्र!
Top 10 Anti-vaxxers Who Got Owned by COVID
I regret not marrying a girl at least for green card. do you think TPS will remain for a long time?
TPS Work Permit/How long your took?
काेराेना सङ्क्रमणबाट बच्न Immunity बढाउन के के खाने ?How to increase immunity against COVID - 19?
Breathe in. Breathe out.
3 most corrupt politicians in the world
Nas and The Bokas: Coming to a Night Club near you
Mr. Dipak Gyawali-ji Talk is Cheap. US sends $ 200 million to Nepal every year.
Harvard Nepali Students Association Blame Israel for hamas terrorist attacks
TPS Update : Jajarkot earthquake
NOTE: The opinions here represent the opinions of the individual posters, and not of Sajha.com. It is not possible for sajha.com to monitor all the postings, since sajha.com merely seeks to provide a cyber location for discussing ideas and concerns related to Nepal and the Nepalis. Please send an email to admin@sajha.com using a valid email address if you want any posting to be considered for deletion. Your request will be handled on a one to one basis. Sajha.com is a service please don't abuse it. - Thanks.

Sajha.com Privacy Policy

Like us in Facebook!

↑ Back to Top
free counters